An Investigator-Initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses on Dorsal Hands and Forearms

Journal of the American Academy of Dermatology - United States
doi 10.1016/j.jaad.2012.12.181
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Safety, Efficacy, and Patient Acceptability of Imiquimod for Topical Treatment of Actinic Keratoses

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2011English

Efficacy of Topical Imiquimod 3.75% in the Treatment of Actinic Keratosis of the Scalp in Immunosuppressed Patients: Our Case Series.

Journal of Dermatological Treatment
Dermatology
2019English

Imiquimod 5% Cream for the Treatment of Actinic Keratosis of the Eyelid

Beyoglu Eye Journal
2017English

Efficacy of Imiquimod 5% Cream in the Treatment of Equine Sarcoids: A Pilot Study

Veterinary Dermatology
Veterinary
2006English

Ingenol Mebutate: An Emerging Therapy in the Treatment of Actinic Keratoses

Current Dermatology Reports
Dermatology
2013English

Efficacy of 0.5% 5-Fluorouracil Cream and Absence of Undesirable Secondary Effects in the Treatment of Grade III Actinic Keratoses in the Presence of 5% Dobesilate

International Journal of Cancer Studies & Research
2015English

Cost-Effectiveness Analysis of Ingenolo Mebutato Verse Imiquimod in the Treatment of Actinic Keratoses in the Perspective of the Italian Health System

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses

Dermatology and Therapy
Dermatology
2012English

The Clinical Efficacy and Safety Study of Pci Remedial Treatment After The

Heart
Cardiovascular MedicineCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy